Scrip
Herceptin gets first recommendation for subset of stomach cancer patients in EU
21 December 2009
Malini Guha
Roche's (Genentech) breast cancer drug Herceptin (trastuzumab) has received its first recommendation for approval anywhere in the world, from the EU's
CHMP, for the first-line treatment of about 16% of patients with HER2-positive metastatic stomach (gastric) cancer.
Roche said that the EU was...
Please Login to read the full article.
21 December 2009
Malini Guha
Roche said that the EU was...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Herceptin approved in EU for HER2-positive stomach cancer
- Roche to file Herceptin for stomach cancer after survival benefit shown in Phase III
- Roche tumbles after Avastin disappoints in Phase III adjuvant colon cancer trial
- GSK receives positive opinions in EU for Votrient and Tyverb
COMMENT
Other Informa Comment
EVENTS
Today
Berlin, Germany
Today
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
